Federica Gillone

Federica Gillone has extensive experience in the field of Molecular Biology, currently serving as a Senior Scientist and Head of the Nucleic Acid Technologies (NAT) Safety Lab at Merck Group since March 2008. In this role, Federica leads the Biological Quality Control lab focused on developing, optimizing, and validating GMP-compliant methods for detecting adventitious agents in therapeutic protein production. Previous positions at Merck Group include Scientist and Associate Scientist, where Federica contributed to method development and regulatory submissions. Additionally, Federica completed a PhD in Molecular Medicine at Università degli Studi di Torino, complemented by advanced degrees in Molecular Biotechnology.